Detection of cytomegalovirus DNA in fecal samples in the diagnosis of enterocolitis after allogeneic stem cell transplantation

Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia
Alzbeta ZavrelovaPavel Zak

Abstract

Cytomegalovirus enterocolitis is a rare but potentially life threatening complication after allogeneic stem cell transplantation. Its early diagnosis and treatment are essential for a successful outcome. To determine the potential benefit of fecal CMV DNA detection in the diagnosis of CMV colitis among stem cell transplant recipients. Biopsies from the lower gastrointestinal tract, taken during 69 episodes of diarrhea, were compared with fecal samples previously examined for CMV DNA in 45 patients after allogeneic stem cell transplantation. Six confirmed cases of CMV colitis were observed, with 16 out of 69 (23%) fecal samples proving positive for CMV DNA. Only one positive sample correlated with histologically confirmed CMV colitis, and 15 samples were evaluated as false positive. These results provide a 16.7% sensitivity and 76.2% specificity in the diagnosis of CMV enterocolitis. The examination of fecal samples for the presence of CMV DNA has very low potential in the diagnosis of CMV enterocolitis after allogeneic stem cell transplantation; therefore, a biopsy of the gastrointestinal mucosa is still warranted for correct diagnosis.

References

Jan 15, 2002·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·J A van BurikD J Weisdorf
Mar 27, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Per LjungmanCarlos Paya
Jul 3, 2007·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·K J RolfeM D Curran
Dec 17, 2008·Expert Review of Gastroenterology & Hepatology·Neelima Reddy, C Mel Wilcox
Mar 11, 2009·Gastrointestinal Endoscopy·Gaurav AroraGeorge Triadafilopoulos
Jun 22, 2010·Reviews in Medical Virology·Michael J CannonTerri B Hyde
Feb 26, 2011·Journal of Virological Methods·Pattara KhamrinHiroshi Ushijima
Mar 31, 2011·World Journal of Gastroenterology : WJG·Naoyoshi NagataNaomi Uemura
Sep 29, 2011·Gastrointestinal Endoscopy·Deborah A FisherJason A Dominitz
May 17, 2012·Current Gastroenterology Reports·David M You, Mark D Johnson
Aug 21, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christine M DurandDionissios Neofytos
Sep 18, 2013·Cancer Letters·Ella J Ariza-HerediaRoy F Chemaly
Dec 3, 2014·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Tina GanzenmuellerAlbert Heim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.